{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:00:21Z","timestamp":1777550421937,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health and Welfare"},{"name":"Ministry of Science and Technology","award":["NSC 99A1-VCSP01-014"],"award-info":[{"award-number":["NSC 99A1-VCSP01-014"]}]},{"name":"Taiwan CDC"},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["02A1-IVPP12-014"],"award-info":[{"award-number":["02A1-IVPP12-014"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2017.02.042","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T03:45:36Z","timestamp":1488858336000},"page":"3134-3139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture"],"prefix":"10.1016","volume":"36","author":[{"given":"Chia-Chyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Shin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Yung-Chih Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Ron","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar-Bin","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pele","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.042_b0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan","volume":"341","author":"Ho","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.042_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.02.042_b0015","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.02.042_b0025","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2017.02.042_b0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coviro.2012.02.009","article-title":"Recent advances in the molecular epidemiology and control of human enterovirus 71 infection","volume":"2","author":"McMinn","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2017.02.042_b0035","doi-asserted-by":"crossref","first-page":"831282","DOI":"10.1155\/2012\/831282","article-title":"Immunological evaluation and comparison of different EV71 vaccine candidates","volume":"2012","author":"Chou","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2017.02.042_b0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.042_b0045","doi-asserted-by":"crossref","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.042_b0050","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0055","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.vaccine.2013.03.015","article-title":"A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine","volume":"31","author":"Cheng","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0060","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.02.042_b0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.vaccine.2011.11.087","article-title":"Selection and characterization of vaccine strain for Enterovirus 71 vaccine development","volume":"30","author":"Chang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0070","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.042_b0075","first-page":"167","article-title":"Safety issues of animal products used in serum-free media","volume":"99","author":"Merten","year":"1999","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2017.02.042_b0080","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.vaccine.2004.05.037","article-title":"Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","article-title":"High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture","volume":"25","author":"Liu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0090","doi-asserted-by":"crossref","first-page":"e0136420","DOI":"10.1371\/journal.pone.0136420","article-title":"Inactivated Enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.042_b0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","article-title":"Bioreactor concepts for cell culture-based viral vaccine production","volume":"14","author":"Gallo-Ram\u00edrez","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.02.042_b0100","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/bit.10629","article-title":"Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells","volume":"82","author":"Voisard","year":"2003","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.02.042_b0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bit.20423","article-title":"Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor","volume":"90","author":"Bleckwenn","year":"2005","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.02.042_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BA20050233","article-title":"Bioreactor systems for the production of biopharmaceuticals from animal cells","volume":"45","author":"Warnock","year":"2006","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.vaccine.2017.02.042_b0115","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1586\/erv.09.128","article-title":"Continuous cell lines as a production system for influenza vaccines","volume":"8","author":"Genzel","year":"2009","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.02.042_b0120","series-title":"Bioprocess engineering: basic concepts","author":"Shuler","year":"2001"},{"key":"10.1016\/j.vaccine.2017.02.042_b0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbiotec.2005.07.018","article-title":"Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor","volume":"121","author":"Trabelsi","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.02.042_b0130","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","article-title":"A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions","volume":"25","author":"Rourou","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.042_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6750-11-84","article-title":"Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture","volume":"11","author":"Petiot","year":"2011","journal-title":"BMC Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T07:10:14Z","timestamp":1568877014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X17302451"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}